Bixiye
BC-COM_PharmProgPolicyNotifctn_04262022_Eff 6.14.22_FINAL.pdf
Natiijooyinka Raadinta
Soo bandhiga 2121 - 2130 ee natiijooyinka 4140
Bixiye
QP36-22 Commercial Pharmacy Benefit Exclusion for Xolair®
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP37-22 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: VoxzogoTM (vosoritide)
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP38-22 Updates to Authorization Request with Unlisted or Unspecified Codes
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP40-22 Temporary Rate Increase for Personal Care Attendant (PCA) Services
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
P29-22 2022 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022
Bixiye
P25-22 Update: Modifier -52, -CO and -CQ Reimbursement Changes – Effective July 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022
Bixiye
P26-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options prior authorization and medical policy requirements
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022